BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8709204)

  • 1. The CR1 and CR3 domains of the adenovirus type 5 E1A proteins can independently mediate activation of ATF-2.
    Duyndam MC; van Dam H; van der Eb AJ; Zantema A
    J Virol; 1996 Sep; 70(9):5852-9. PubMed ID: 8709204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
    Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
    Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.
    Wong HK; Ziff EB
    J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun.
    Hagmeyer BM; König H; Herr I; Offringa R; Zantema A; van der Eb A; Herrlich P; Angel P
    EMBO J; 1993 Sep; 12(9):3559-72. PubMed ID: 8253081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATF-2 contains a phosphorylation-dependent transcriptional activation domain.
    Livingstone C; Patel G; Jones N
    EMBO J; 1995 Apr; 14(8):1785-97. PubMed ID: 7737129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.
    Kornuc M; Kliewer S; Garcia J; Harrich D; Li C; Gaynor R
    J Virol; 1990 May; 64(5):2004-13. PubMed ID: 2139139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter.
    Morooka H; Bonventre JV; Pombo CM; Kyriakis JM; Force T
    J Biol Chem; 1995 Dec; 270(50):30084-92. PubMed ID: 8530413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP-independent activation of the adenovirus type 12 E2 promoter correlates with the recruitment of CREB-1/ATF-1, E1A(12S), and CBP to the E2-CRE.
    Fax P; Lipinski KS; Esche H; Brockmann D
    J Biol Chem; 2000 Mar; 275(12):8911-20. PubMed ID: 10722738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural determinants outside of the leucine zipper influence the interactions of CREB and ATF-2: interaction of CREB with ATF-2 blocks E1a-ATF-2 complex formation.
    Abdel-Hafiz HA; Chen CY; Marcell T; Kroll DJ; Hoeffler JP
    Oncogene; 1993 May; 8(5):1161-74. PubMed ID: 8479741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300 and ATF-2 are components of the DRF complex, which regulates retinoic acid- and E1A-mediated transcription of the c-jun gene in F9 cells.
    Kawasaki H; Song J; Eckner R; Ugai H; Chiu R; Taira K; Shi Y; Jones N; Yokoyama KK
    Genes Dev; 1998 Jan; 12(2):233-45. PubMed ID: 9436983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents.
    van Dam H; Wilhelm D; Herr I; Steffen A; Herrlich P; Angel P
    EMBO J; 1995 Apr; 14(8):1798-811. PubMed ID: 7737130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional control by adenovirus E1A conserved region 3 via p300/CBP.
    Pelka P; Ablack JN; Torchia J; Turnell AS; Grand RJ; Mymryk JS
    Nucleic Acids Res; 2009 Mar; 37(4):1095-106. PubMed ID: 19129215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein.
    van Dam H; Duyndam M; Rottier R; Bosch A; de Vries-Smits L; Herrlich P; Zantema A; Angel P; van der Eb AJ
    EMBO J; 1993 Feb; 12(2):479-87. PubMed ID: 8382609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo association of adenovirus large E1A protein with the human mediator complex in adenovirus-infected and -transformed cells.
    Wang G; Berk AJ
    J Virol; 2002 Sep; 76(18):9186-93. PubMed ID: 12186902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of a novel member of the gene family encoding the cAMP response element-binding protein CRE-BP1.
    Nomura N; Zu YL; Maekawa T; Tabata S; Akiyama T; Ishii S
    J Biol Chem; 1993 Feb; 268(6):4259-66. PubMed ID: 8440710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the RB family, permitting transactivation of the E2F-dependent promoter.
    Pützer BM; Rumpf H; Rega S; Brockmann D; Esche H
    J Virol; 1997 Dec; 71(12):9538-48. PubMed ID: 9371617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation.
    Falvo JV; Parekh BS; Lin CH; Fraenkel E; Maniatis T
    Mol Cell Biol; 2000 Jul; 20(13):4814-25. PubMed ID: 10848607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K.
    Schmitz ML; Indorf A; Limbourg FP; Städtler H; Traenckner EB; Baeuerle PA
    Mol Cell Biol; 1996 Aug; 16(8):4052-63. PubMed ID: 8754803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    De Cesare D; Vallone D; Caracciolo A; Sassone-Corsi P; Nerlov C; Verde P
    Oncogene; 1995 Jul; 11(2):365-76. PubMed ID: 7624151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E1A + cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition.
    Pospelova TV; Medvedev AV; Kukushkin AN; Svetlikova SB; van der Eb AJ; Dorsman JC; Pospelov VA
    Gene Expr; 1999; 8(1):19-32. PubMed ID: 10543728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.